A macrophage cell membrane-coated cascade-targeting photothermal nanosystem for combating intracellular bacterial infections
Source abstract
Abstract
Current antibacterial interventions encounter formidable challenges when confronting intracellular bacteria, attributable to their clustering within phagocytes, particularly macrophages, evading host immunity and resisting antibiotics. Herein, we have developed an intelligent cell membrane-based nanosystem, denoted as MM@DAu NPs, which seamlessly integrates cascade-targeting capabilities with controllable antibacterial functions for the precise elimination of intracellular bacteria. MM@DAu NPs feature a core comprising D-alanine-functionalized gold nanoparticles (DAu NPs) enveloped by a macrophage cell membrane (MM) coating. Upon administration, MM@DAu NPs harness the intrinsic homologous targeting ability of their macrophage membrane to infiltrate bacteria-infected macrophages. Upon internalization within these host cells, exposed DAu NPs from MM@DAu NPs selectively bind to intracellular bacteria through the bacteria-targeting agent, D-alanine present on DAu NPs. This intricate process establishes a cascade mechanism that efficiently targets intracellular bacteria. Upon exposure to near-infrared irradiation, the accumulated DAu NPs surrounding intracellular bacteria induce local hyperthermia, enabling precise clearance of intracellular bacteria. Further validation in animal models infected with the typical intracellular bacteria, Staphylococcus aureus, substantiates the exceptional cascade-targeting efficacy and photothermal antibacterial potential of MM@DAu NPs in vivo. Therefore, this integrated cell membrane-based cascade-targeting photothermal nanosystem offers a promising approach for conquering persistent intracellular infections without drug resistance risks. STATEMENT OF SIGNIFICANCE: Intracellular bacterial infections lead to treatment failures and relapses because intracellular bacteria could cluster within phagocytes, especially macrophages, evading the host immune system and resisting antibiotics. Herein, we have developed an intelligent cell membrane-based nanosystem MM@DAu NPs, which is designed to precisely eliminate intracellular bacteria through a controllable cascade-targeting photothermal antibacterial approach. MM@DAu NPs combine D-alanine-functionalized gold nanoparticles with a macrophage cell membrane coating. Upon administration, MM@DAu NPs harness the homologous targeting ability of macrophage membrane to infiltrate bacteria-infected macrophages. Upon internalization, exposed DAu NPs from MM@DAu NPs selectively bind to intracellular bacteria through the bacteria-targeting agent, enabling precise clearance of intracellular bacteria through local hyperthermia. This integrated cell membrane-based cascade-targeting photothermal nanosystem offers a promising avenue for conquering persistent intracellular infections without drug resistance risks.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. Intracellular habitation of Staphylococcus Aureus: molecular mechanisms and prospects for antimicrobial therapy10.3390/biomedicines10081804 ↗
2. Mycobacterium tuberculosis infection of host cells in space and time10.1093/femsre/fuz006 ↗
3. Salmonella enterica: living a double life in epithelial cells10.1016/j.mib.2014.10.010 ↗
4. Novel antibody-antibiotic conjugate eliminates intracellular S. aureus10.1038/nature16057 ↗
5. The role of macrophages in Staphylococcus aureus infection10.3389/fimmu.2020.620339 ↗
6. HClO-activated fluorescence and photosensitization from an AIE nanoprobe for image-guided bacterial ablation in phagocytes10.1002/adma.202005222 ↗
7. Cerebrospinal fluid can exit into the skull bone marrow and instruct cranial hematopoiesis in mice with bacterial meningitis10.1038/s41593-022-01060-2 ↗
8. Skeletal infections: microbial pathogenesis, immunity and clinical management10.1038/s41579-022-00686-0 ↗
9. Clearance of intracellular Klebsiella pneumoniae infection using gentamicin-loaded nanoparticles10.1016/j.jconrel.2018.04.040 ↗
10. Intracellular replication of Streptococcus pneumoniae inside splenic macrophages serves as a reservoir for septicaemia10.1038/s41564-018-0147-1 ↗
11. Innate immunity to intracellular pathogens: macrophage receptors and responses to microbial entry10.1111/j.1600-065X.2010.00989.x ↗
12. Macrophage defense mechanisms against intracellular bacteria10.1111/imr.12266 ↗
13. The importance of understanding the infectious microenvironment10.1016/S1473-3099(21)00122-5 ↗
14. Review: the role and mechanisms of macrophage autophagy in sepsis10.1007/s10753-018-0890-8 ↗
15. Targeted drug delivery systems for eliminating intracellular bacteria10.1002/mabi.202200311 ↗
16. Manipulation of host cell organelles by intracellular pathogens10.3390/ijms22126484 ↗
17. Bioinspired drug delivery strategies for repurposing conventional antibiotics against intracellular infections10.1016/j.addr.2021.113948 ↗
18. Infection microenvironment-related antibacterial nanotherapeutic strategies10.1016/j.biomaterials.2021.121249 ↗
19. NOD proteins: regulators of inflammation in health and disease10.1038/nri3565 ↗
20. Targeted polymer-based antibiotic delivery system: a promising option for treating bacterial infections via macromolecular approaches10.1016/j.progpolymsci.2021.101389 ↗
21. Conjugated polymer-based photothermal therapy for killing microorganisms10.1021/acsapm.0c00718 ↗
22. Starvation therapy enabled "switch-on" NIR-II photothermal nanoagent for synergistic in situ photothermal immunotherapy10.1016/j.nantod.2022.101461 ↗
23. Compact plasmonic blackbody for cancer theranosis in the near-infrared II window10.1021/acsnano.7b08725 ↗
24. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer10.1021/acsnano.6b03148 ↗
25. Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinoma10.1136/jitc-2022-005968 ↗
26. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knockout mice10.1172/JCI119798 ↗
27. Cell membrane coating nanotechnology10.1002/adma.201706759 ↗
28. Macrophage membrane coated nanoparticles: a biomimetic approach for enhanced and targeted delivery10.1039/D1BM01664D ↗
29. Macrophage-evading and tumor-specific apoptosis inducing nanoparticles for targeted cancer therapy10.1016/j.apsb.2022.05.010 ↗
30. Mannosylated graphene oxide as macrophage-targeted delivery system for enhanced intracellular M. tuberculosis killing efficiency10.1016/j.msec.2019.109777 ↗
31. Nanomaterials-based photothermal therapy and its potentials in antibacterial treatment10.1016/j.jconrel.2020.08.055 ↗
32. Localized degradation of neutrophil extracellular traps by photoregulated enzyme delivery for cancer immunotherapy and metastasis suppression10.1021/acsnano.1c09318 ↗
33. Gold-coated magnetic nanoparticle as a nanotheranostic agent for magnetic resonance imaging and photothermal therapy of cancer10.1007/s10103-017-2267-x ↗
34. Cancer cell membrane camouflaged cascade bioreactor for cancer targeted starvation and photodynamic therapy10.1021/acsnano.7b02533 ↗
35. Macrophage membrane functionalized biomimetic nanoparticles for targeted anti-atherosclerosis applications10.7150/thno.47841 ↗
36. Microfluidic sonication to assemble exosome membrane-coated nanoparticles for immune evasion-mediated targeting10.1021/acs.nanolett.9b02841 ↗
37. CD68: potential contributor to inflammation and RPE cell dystrophy10.1007/978-3-031-27681-1_30 ↗
38. Artificial nanotargeted cells with stable photothermal performance for multimodal imaging-guided tumor-specific therapy10.1021/acsnano.0c00771 ↗
39. Fibroblast membrane-camouflaged nanoparticles for inflammation treatment in the early stage10.1038/s41368-021-00144-2 ↗
40. Bioengineered stem cell membrane functionalized nanocarriers for therapeutic targeting of severe hindlimb ischemia10.1016/j.biomaterials.2018.08.018 ↗
41. Exosome-encapsulated antibiotic against intracellular infections of methicillin-resistant Staphylococcus aureus10.2147/IJN.S179380 ↗
42. pH-responsive polymer-drug conjugate: an effective strategy to combat the antimicrobial resistance10.1002/adfm.202002655 ↗
43. Coating of a novel antimicrobial nanoparticle with a macrophage membrane for the selective entry into infected macrophages and killing of intracellular staphylococci10.1002/adfm.202004942 ↗
44. Cascade-targeting poly(amino acid) nanoparticles eliminate intracellular bacteria via on-site antibiotic delivery10.1002/adma.202109789 ↗
45. The SPOR domain, a widely conserved peptidoglycan binding domain that targets proteins to the site of cell division10.1128/JB.00118-17 ↗
46. Controlled growth of CdS nanoparticles in polyurushiol matrices10.1016/j.porgcoat.2008.09.001 ↗
47. Chemical coatings relying on the self-polymerization of catechol for retrievable vena cava filters10.1039/C7NJ04138A ↗
48. Platinum deposition on carbon nanotubes via chemical modification10.1021/cm970364z ↗
49. Mechanism of electrochemical L-cysteine oxidation on Pt10.1002/celc.201801575 ↗
50. Self-assembly of heterogeneous bilayers stratified by Au–S and hydrogen bonds on Au(111)10.1039/D2CP03356A ↗
51. Synthesis and structural determination of multidentate 2,3-dithiol-stabilized Au clusters10.1021/ja9076149 ↗
52. Macrophages as tools and targets in cancer therapy10.1038/s41573-022-00520-5 ↗
53. Pretreated macrophage-membrane-coated gold nanocages for precise drug delivery for treatment of bacterial infections10.1002/adma.201804023 ↗
54. Macrophage-targeted nanomedicine for the diagnosis and treatment of atherosclerosis10.1038/s41569-021-00629-x ↗
55. Macrophage migration inhibitory factor (MIF) and its homolog D-dopachrome tautomerase (D-DT) are significant promotors of UVB-but not chemically induced non-melanoma skin cancer
56. Cell wall hydrolases in bacteria: insight on the diversity of cell wall amidases, glycosidases and peptidases toward peptidoglycan10.3389/fmicb.2019.00331 ↗
57. Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus10.1038/nrmicro3161 ↗
58. Exploring the antibacteria performance of multicolor Ag, Au, and Cu nanoclusters10.1021/acsami.8b22143 ↗